Published in Br Heart J on April 01, 1989
Staphylococcus aureus endocarditis. A review of 119 cases. Arch Intern Med (1986) 1.24
Diagnostic accuracy of M-mode echocardiography in active infective endocarditis and prognostic implications of ultrasound-detectable vegetations. Am Heart J (1982) 1.05
Intravenous drug addiction--staphylococcal septicemia--pulmonary embolism: a triad pathognomonic for tricuspid valve endocarditis? Scand J Infect Dis (1983) 0.97
Impact of a policy of direct admission to a coronary care unit on use of thrombolytic treatment. Br Heart J (1989) 4.62
Coronary thrombolysis with intravenous anisoylated plasminogen-streptokinase complex BRL 26921. Br Heart J (1985) 2.92
Pre-hospital opiate and aspirin administration in patients with suspected myocardial infarction. BMJ (1994) 2.46
Treatment of atrial fibrillation in a district general hospital. Br Heart J (1994) 2.40
ABC of palliative care. Non-malignant conditions. BMJ (1998) 2.24
Cardiac troponin T. Lancet (1993) 2.13
Secondary harmonic imaging overestimates left ventricular mass compared to fundamental echocardiography. Eur J Echocardiogr (2003) 2.11
Hemodynamic and coronary effects of intravenous eletriptan, a 5HT1B/1D-receptor agonist. Clin Pharmacol Ther (1999) 2.06
Use of fax facility improves decision making regarding thrombolysis in acute myocardial infarction. Heart (1997) 2.01
The genetic determination of left ventricular mass in healthy adults. Eur Heart J (2003) 1.77
Electrocardiographic prediction of coronary artery patency after thrombolytic treatment in acute myocardial infarction: use of the ST segment as a non-invasive marker. Br Heart J (1988) 1.75
Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J (1998) 1.71
Humoral and cellular immune responses up to 7.5 years after administration of streptokinase for acute myocardial infarction. Eur Heart J (1999) 1.64
Direct admission to the coronary care unit by the ambulance service for patients with suspected myocardial infarction. Heart (1997) 1.60
Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis. Am Heart J (1996) 1.59
Early treatment of myocardial infarction in the community. Br Med J (1978) 1.58
Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators. Circulation (1997) 1.47
Effects of nadolol on arrhythmias during laparoscopy performed under general anaesthesia. Br J Anaesth (1988) 1.41
Assessment by general practitioners of suitability of thrombolysis in patients with suspected acute myocardial infarction. Br Heart J (1993) 1.40
Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. Br Heart J (1995) 1.38
Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels. Lancet (1983) 1.36
Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med (1984) 1.31
Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation. Circulation (1993) 1.26
Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG. Br Heart J (1992) 1.22
Angiographic patency study of anistreplase versus streptokinase in acute myocardial infarction. Lancet (1990) 1.20
Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med (1983) 1.16
Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation (1982) 1.16
A prospective randomized trial of tocainide in patients following myocardial infarction. Am Heart J (1980) 1.11
The use of BRL26921 (APSAC) as fibrinolytic therapy in acute myocardial infarction. Eur Heart J (1985) 1.11
Relation between extent of coronary artery disease and severity of hyperlipoproteinaemia. Br Heart J (1975) 1.10
Wide variation in the use of thrombolytic therapy among junior doctors in south and central Scotland. Health Bull (Edinb) (1996) 1.09
Leucocyte ascorbic acid levels after acute myocardial infarction. Br Heart J (1972) 1.08
Haemodynamic effects of prenalterol in patients with coronary heart disease. Br Heart J (1980) 1.07
Diagnosis and treatment of digoxin toxicity. Postgrad Med J (1993) 1.06
Pathophysiologic assessment of hypertensive heart disease with echocardiography. Am J Cardiol (1977) 1.06
The effect of i.v. sumatriptan, a selective 5-HT1-receptor agonist on central haemodynamics and the coronary circulation. Br J Clin Pharmacol (1992) 1.06
Leaking false aneurysm of right coronary saphenous vein graft; successful treatment by percutaneous coil embolisation. Br Heart J (1992) 1.02
Immediate hemodynamic effects of a dopamine-receptor agonist (fenoldopam) in patients with essential hypertension. Circulation (1984) 1.01
Disparate cardiovascular effects of obesity and arterial hypertension. Am J Med (1983) 1.00
ABC of sports medicine. Sudden death in sport. BMJ (1994) 0.99
Greater renal vascular involvement in the black patient with essential hypertension. A comparison of systemic and renal hemodynamics in black and white patients. Miner Electrolyte Metab (1984) 0.99
Alcoholic ketoacidosis: a case report. Scott Med J (1987) 0.99
Malignant hypertension associated with use of oral contraceptives. Br Heart J (1975) 0.98
Familial pattern of corticosteroids and their metabolism in adult human subjects--the Scottish Adult Twin Study. J Clin Endocrinol Metab (1999) 0.98
Racial differences in cardiac adaptation to essential hypertension determined by echocardiographic indexes. J Am Coll Cardiol (1983) 0.97
Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension. Am J Cardiol (1984) 0.97
Questionnaire survey of thrombolytic treatment in accident and emergency departments in the United Kingdom. BMJ (1998) 0.97
Serial measurements of left ventricular dimensions by echocardiography. Assessment of week-to-week, inter- and intraobserver variability in normal subjects and patients with valvular heart disease. Br Heart J (1980) 0.96
Intracoronary thrombolytic therapy performed within a coronary care unit: one year's experience. Scott Med J (1986) 0.96
Exercise prescription in adults with congenital heart disease: a long way to go. Heart (2000) 0.96
Ticrynafen: a novel uricosuric antihypertensive natriuretic agent. Arch Intern Med (1978) 0.95
Relation between prognosis and the blood pressure before and during treatment of hypertensive patients. Clin Sci Mol Med Suppl (1978) 0.95
Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme. Heart (2006) 0.94
The long-term management of the patient with an aortic coarctation repair. Eur Heart J (1998) 0.94
Antiarrhythmic drugs. Br Med J (Clin Res Ed) (1983) 0.94
Electrophysiological effects of felodipine. Drugs (1985) 0.93
Borderline hypertension: relationship between age, hemodynamics and circulating catecholamines. Circulation (1981) 0.93
Immediate hemodynamic effects of a new calcium-channel blocking agent (nitrendipine) in essential hypertension. Am J Cardiol (1983) 0.93
Optimising direct access ECHO referral in suspected heart failure. Scott Med J (2000) 0.93
The ergoreflex in patients with chronic stable heart failure. Int J Cardiol (1999) 0.93
Pathophysiologic assessment of left ventricular hypertrophy and strain in asymptomatic patients with essential hypertension. J Am Coll Cardiol (1989) 0.91
Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: initial patency and influence of maintained infusion on reocclusion rate. Am J Cardiol (1987) 0.91
Fragmin in unstable angina pectoris or in non-Q-wave acute myocardial infarction (the FRIC study). Fragmin in Unstable Coronary Artery Disease. Am J Cardiol (1997) 0.90
Cardiovascular changes after weight reduction in obesity hypertension. Ann Intern Med (1983) 0.90
Outcomes of transposition of the great arteries in the ear of atrial inflow correction. Heart (1998) 0.90
Plasma fibrinogen and fibrin D-dimer in patients with atrial fibrillation: effects of cardioversion to sinus rhythm. Int J Cardiol (1995) 0.89
Cardiovascular effects of a new inotropic agent, U. K. 14275, in patients with coronary heart disease. Br J Clin Pharmacol (1977) 0.88
Management of suspected myocardial infarction before admission: updated audit. BMJ (1998) 0.88
Left ventricular hypertrophy in hypertension. N Engl J Med (1999) 0.88
Balsalazide-induced myocarditis. Int J Cardiol (2007) 0.87
The prevalence of left ventricular hypertrophy in elite professional footballers. Int J Cardiol (1999) 0.87
Thrombogenesis in mitral regurgitation and aortic stenosis. Angiology (1996) 0.87
The determination of carotid intima medial thickness in adults--a population-based twin study. Atherosclerosis (2003) 0.87
Echocardiographic diastolic ventricular abnormality in hypertensive heart disease: atrial emptying index. Am J Cardiol (1981) 0.87
Significance of ventricular arrhythmias in systemic hypertension with left ventricular hypertrophy. Am J Cardiol (1992) 0.86
Beta-adrenoreceptor blockade in hypertension. Am J Med (1976) 0.86
Antihypertensive and renal effects of tienilic acid. Postgrad Med J (1979) 0.86
Some aspects of the clinical pharmacology of intravenous disopyramide after myocardial infarction. J Int Med Res (1976) 0.86
Comparison of saruplase and alteplase in acute myocardial infarction. SESAM Study Group. The Study in Europe with Saruplase and Alteplase in Myocardial Infarction. Am J Cardiol (1997) 0.85
Natural biventricular hypertrophy in normotensive rats. I. Physical and hemodynamic characteristics. Am J Physiol (1979) 0.84
Failure of single dose amoxycillin as prophylaxis against endocarditis. Br Med J (Clin Res Ed) (1984) 0.84
Symptomatic and silent myocardial ischaemia in hypertensive patients with left ventricular hypertrophy. Br Heart J (1992) 0.84
Increased titres of anti-human heat shock protein 60 predict an adverse one year prognosis in patients with acute cardiac chest pain. Heart (2005) 0.84
CABG in the elderly: the Glasgow experience. Gerontology (1989) 0.84
Pre-dosing antibody levels and efficacy of thrombolytic drugs containing streptokinase. Br Heart J (1994) 0.83